<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    No articles found.

    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused, biopharmaceutical...

    Neurocrine Biosciences (Nasdaq: NBIX) is a neur...

    United-Guardian, Inc.

    United-Guardian, Inc.

    United-Guardian, Inc. ("United") is a diversified company that conducts research, ...

    United-Guardian, Inc. ("United") is a diversifi...

    Reckitt Benckiser Group Plc.

    Reckitt Benckiser Group Plc.

    RB is the global leading consumer health, hygiene and home company. Driven by a pu...

    RB is the global leading consumer health, hygie...

    Catalyst Biosciences, Inc.

    Catalyst Biosciences, Inc.

    Catalyst is focused on developing novel medicines to address serious medical condi...

    Catalyst is focused on developing novel medicin...

    PDS Biotechnology Corporation

    PDS Biotechnology Corporation

    PDS Biotechnology has a growing pipeline of clinical-stage immunotherapies to trea...

    PDS Biotechnology has a growing pipeline of cli...

    Innovate Biopharmaceuticals, Inc.

    Innovate Biopharmaceuticals, Inc.

    Innovate is a publicly traded (Nasdaq: INNT) clinical stage biotechnology company ...

    Innovate is a publicly traded (Nasdaq: INNT) cl...

    ProQR Therapeutics N.V.

    ProQR Therapeutics N.V.

    We are ProQR, a company on a mission to create new medicines for patients in need....

    We are ProQR, a company on a mission to create ...

    Alexion Pharmaceuticals, Inc.

    Alexion Pharmaceuticals, Inc.

    Alexion (NASDAQ: ALXN) is a global biopharmaceutical company focused on serving pa...

    Alexion (NASDAQ: ALXN) is a global biopharmaceu...

    BioMarin Pharmaceutical Inc.

    BioMarin Pharmaceutical Inc.

    At BioMarin, we focus on developing first-in-class and best-in-class therapeutics ...

    At BioMarin, we focus on developing first-in-cl...